[Dalargin in the treatment of arteriosclerosis obliterans of the lower extremities].
V A
VA
Dudko
N A
NA
Fedorova
V A
VA
Didenko
G K
GK
Zoloev
D000328:Adult; D001162:Arteriosclerosis Obliterans / Q000188:drug therapy*; D002986:Clinical Trials as Topic; D004341:Drug Evaluation; D004743:Enkephalin, Leucine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D016308:Enkephalin, Leucine-2-Alanine / Q000031:analogs & derivatives*; D006801:Humans; D007866:Leg / Q000098:blood supply*; D008875:Middle Aged; D010919:Placebos; D013565:Sympatholytics / Q000627:therapeutic use
D010919:Placebos; D013565:Sympatholytics; D004743:Enkephalin, Leucine; D016308:Enkephalin, Leucine-2-Alanine; C040996:enkephalin-Leu, Ala(2)-Arg(6)-
Dalargin pri lechenii obliteriruiushchego ateroskleroza arteriĭi nizhnikh konechnosteĭ.